ZNTL (Zentalis Pharmaceuticals) FFO


ZNTL Zentalis Pharmaceuticals Inc ZNTL
30 GF Score
Price $4.72
! 3 Warning Signs
View Full Analysis

What is Zentalis Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

ZNTL
30GF Score
Zentalis Pharmaceuticals Inc ZNTL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentalis Pharmaceuticals Business Description

Address 10275 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
30GF Score

Get the complete analysis for ZNTL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.72
Price